SUMMARY -Th e aim of the study was to determine whether serum vitamin D level is lower in female patients with glaucoma as compared with control group. Th e mechanism by which vitamin D reduces intraocular pressure is not fully clarifi ed. Almost all tissues possess vitamin D receptor (VDR). Th e mice lacking VDR (VDR knockout mice) have greatly contributed to the understanding of the general vitamin D physiologic function. VDR has been found in some ganglion layer cells, external and internal nuclear layers of retina, and in retinal pigment epithelium, while VDR epitopes have also been found in the ciliary body epithelium, pointing to the role of this protein in eye physiology. Th e 1,25(OH)2D3 modulates expression of the genes involved in the regulation of intraocular pressure in non-human primates. Extracellular matrix can be remodeled by 1,25(OH)2D3 treatment. Actin disruption can lead to cell morphology alteration, trabecular meshwork relaxation and intraocular pressure reduction. Th is observational cross-sectional study included 90 female glaucoma subjects aged 45-55 and 50 glaucoma free female subjects as control group. Results of a pilot study conducted in 20 glaucoma subjects and 20 control subjects are presented below. All study subjects underwent history taking, complete ophthalmologic examination and serum vitamin D determination. Th e mean serum vitamin D level was 32.31 nmol/L in glaucoma patients and 64.17 nmol/L in control subjects. Serum vitamin D level was statistically signifi cantly lower in glaucoma patients as compared with control group (p<0.05).
Introduction
Glaucoma is a multifactorial optic neuropathy characterized by acquired loss of optic nerve fi bers. Current hypotheses on the potential pathogenic mechanisms in the onset of glaucomatous optic neuropathy include exotoxic lesion due to excessive retinal glutamate release, reduction in neuronal growth factor, peroxynitrite toxicity due to the increased activity of nitric monoxide synthetase, immune mediated optic nerve lesion, and oxidative stress.
Th ere are no generally accepted guidelines on adequate vitamin D (1,25(OH)2D3) level. Serum vitamin D levels of 50-75 nmol/L (20-30 ng/mL) are considered as vitamin D insuffi ciency, with adverse eff ects on bone mineral density and possibly on muscle and physical ability [1] [2] [3] [4] . Th e levels <50 nmol/L are considered as vitamin D defi ciency and those <30 nmol/L as severe vitamin D defi ciency, whereas vitamin D levels <20 nmol/L cause serious impairment of bone metabolism, i.e. rickets or osteomalacia, depending on age, as well as myopathy associated with physical inability 4, 5 . As a steroid hormone, vitamin D directly or indirectly regulates 3% of the human genome function 6 . Favorable vitamin D eff ects have been demonstrated in many diseases, e.g., in the prevention of heart attack and stroke, diabetes mellitus type 1 and 2, infections and chronic respiratory diseases, autoimmune diseases, etc. Vitamin D receptor (VDR) has been found in some ganglion layer cells, external and internal nuclear layers of retina, and in retinal pigment epithelium, while VDR epitopes have also been found in the ciliary body epithelium, pointing to the role of this protein in eye physiology. Vitamin D exerts autocrine and paracrine action via VDR 6, 7 . Th e mechanism by which vitamin D reduces intraocular pressure (IOP) has not yet been fully clarifi ed. Th e 1,25(OH)2D3 modulates expression of the genes involved in IOP regulation in non-human primates. Extracellular matrix can be remodeled by 1,25(OH)2D3 treatment, resulting in increased fl uid fl ow along with reduced fl ow resistance by disruption of cellular adhesions and relaxation of contractile molecules 8 . Nitric oxide (NO), a free radical produced by vascular endothelium induced by the endothelial nitric monoxide synthetase (eNOS) enzyme activity, is the key signaling molecule for local regulation of vascular tone. Some studies showed that increased NO levels increased the fl ow rate and thus reduced IOP 9, 10 , whereas others report that the increased NO level led to peroxynitrite toxicity and development of glaucomatous optic neuropathy. Th e 1,25(OH)2D3 inhibits nitric oxide inducible synthetase (iNOS) expression and reduces NO production in stimulated macrophages. Th e macrophage production of 1,25(OH)2D3 has protective eff ect on oxidative lesion caused by NO burst 11 . Th e main hypotheses of the study were prompted by the vitamin D immunomodulatory action on the above mentioned parameters. A suffi cient vitamin D status is associated with a lower risk of rheumatoid arthritis, multiple sclerosis, diabetes mellitus type 1, autoimmune diseases and neurodegenerative diseases such as glaucoma. Despite the growing knowledge about the biological and clinical role of vitamin D, considerable prevalence of vitamin D defi ciency is reported in the populations all over the world, including Croatia 6, 12, 13 . As VDR has been demonstrated in many structures of human eye, this type of research off ers an opportunity for studies at the molecular level and for a novel diagnostic and therapeutic approach in both systemic and local vitamin D administration (autocrine and paracrine vitamin D action). If the results of this study indicate that glaucoma patients aged 45-55 have a decreased serum vitamin D level, it will provide a basis for additional clinical trials.
Patients and Methods

Patients
Th is pilot study included 20 female patients with open-angle glaucoma and 20 control female subjects. Blood samples for vitamin D determination were obtained in late autumn and early spring. Women with any bone metabolism disorder, primary hyperparathyroidism, and those on vitamin D supplementation therapy were not included in the study. Excluded were also women with potentially altered serum vitamin D level for any reason (e.g., suntan studio, work in the open, diet, etc.).
Th e study will assess vitamin D eff ect on glaucoma as a disease using the following procedures: serum vitamin D level will be determined in glaucoma patients and control group; serum vitamin D levels in these two groups will be compared and diff erences calculated; and association of serum vitamin D level with other study parameters of glaucoma development (IOP and optic nerve head lesions) will be assessed.
Methods
History data were obtained and complete ophthalmologic examination performed in study patients. Ophthalmologic examination included visual acuity testing by the subjective method using standard Snellen chart according to the international tables; anterior eye segment biomicroscopy on a biomicroscope (Haag-Streit BM 900, Switzerland); IOP measurement on a Goldmann's applanation tonometer (in mm Hg); fundus examination by direct or indirect ophthalmoscopy; pachymetry (measurement of corneal thickness, in μm); gonioscopy (chamber angle examination); and fi eld of vision analysis by computerized static perimetry according to Humphrey using SITA fast 24-2 (Carl Zeiss Meditec, Dublin, Ca, USA) software.
Venous blood samples (≤5 mL) for determination of serum vitamin D levels were obtained in all study subjects. Total calcium (Ca) was determined on an Au 680 autoanalyzer. Parathyroid hormone (PTH) and vitamin D in plasma were determined by the electrochemiluminescence method using respective reagents.
Results were analyzed by nonparametric and parametric statistical methods (Student's t-test and F-test), with the level of statistical signifi cance set at p<0.05 and 95% confi dence interval (95% CI).
Results
Both study group and control group consisted of 20 female subjects each. Th e mean age of glaucoma patients and control subjects was 51.8 and 49.45 years, respectively. Th e mean serum vitamin D level was 32.31 nmol/L in glaucoma patients and 64.17 nmol/L in control subjects (Figs. 1 and 2) . Th e mean Ca and PTH levels were within the normal range and served only to exclude primary hyperparathyroidism, which was not diagnosed in any of study subjects.
Visual acuity examined by use of Snellen chart was 1.0 with or without correction in both groups. In glaucoma patients, the mean corneal thickness measured by use of a pachymeter was 548.85 μm and 549.85 μm on the right and left eye, respectively. In control group, the respective fi gures were 552.60 μm and 551.90 μm (Fig. 3) . Fundus lesions were found in 17 (85%) glaucoma patients and three (15%) control subjects.
In glaucoma patients, the mean IOP value with therapy was 16.9 mm Hg and 17.2 mm Hg on the right and left eye, respectively, versus 15.85 mm Hg measured on both eyes in control group, yielding no statistically signifi cant between-group diff erence (Figs.  4 and 5) . Intraocular pressure higher than 21 mm Hg was not found in any of the control subjects. Pathologic fi eld of vision with glaucoma associated lesions was recorded in eight (40%) glaucoma patients and two (10%) control subjects.
Th e mean value of the optic nerve cup-to-disc (c/d) ratio measured on the right and left eye was 0.423 and 0.417 in glaucoma patients versus 0.340 and 0.350 in control subjects, respectively; t-test yielded a statistically signifi cant between-group diff erence at the level of p<0.05.
Coeffi cient of variation (CV) for vitamin D levels measured in glaucoma patients was higher compared to control subjects (32.32% vs. 28.33%). Th is relative variability was even more important considering that the mean serum vitamin D level was by 49.96% lower in glaucoma patients compared to control group. Upon calculating standard deviation of these two arithmetic means, followed by their comparison and calculation of common standard deviation of two arithmetic means, statistical signifi cance of the vitamin D standard deviations of the mean was calculated by F-test, which yielded a statistically signifi cant diff erence between these two arithmetic means at the level of p<0.05.
Discussion
Th e objective of this cross-sectional study was to determine whether serum vitamin D level is lower in female patients with glaucoma as compared with control group. Results of a pilot study that included 40 female subjects (20 in glaucoma group and control group each) are reported. Glaucoma group consisted of female patients with open-angle glaucoma, while control group included glaucoma-free female subjects. Glaucoma subjects were recruited from the Glaucoma Registry of the Brod-Posavina County. Th e male to female ratio in the Glaucoma Registry is 30% to 70%. In contrast, most studies worldwide report no sex predominance for glaucoma (e.g., Baltimore, Beaver Dam, and Roscommon studies). Th e Barbados Eye Study found men to have a higher age-adjusted risk of glaucoma than women, the Rotterdam study reports on a three-fold higher risk of glaucoma in men, whereas Dalby study found the risk of glaucoma to be higher in women [14] [15] [16] [17] [18] . Our study subjects were aged 45-55. In this age group, vitamin D defi ciency generally is not as pronounced as in >60 age group. A study conducted by Laktašić-Žerjavić et al. suggested vitamin D to vary 
Conclusion
Th e mean serum vitamin D level was lower in study subjects suff ering from glaucoma as compared to control subjects (32.31 nmol/L vs. 64.17 nmol/L), yielding a statistically signifi cant between-group diff erence (p<0.05). Th is pilot study has justifi ed continuation of the research. If the pilot study results be confi rmed, then vitamin D may be considered a marker in the early diagnosis and prevention of glaucoma.
